PTCT
PTC Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$78.01-0.74%
Price as of Jul 20, 2026
PTCT capital
PTC Therapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -2.19x
- Net debt / equity
- 2.43x
- Debt / assets
- 0.14x
- Debt / EBITDA
- -3.30x
- Net debt / EBITDA
- 3.67x
Liquidity & coverage
- Current ratio
- 2.44x
- Quick ratio
- 2.36x
- Cash ratio
- 2.05x
- Interest coverage
- -0.98x
- EBITDA / interest
- -1.73x
- Working capital
- $1.3B
Cash & dividend
- FCF / debt
- -0.67x
- Cash flow / debt
- -0.55x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.